Stockreport

ProQR Announces Third Quarter 2024 Operating and Financial Results

ProQR Therapeutics N.V. - Ordinary Shares  (PRQR) 
Last proqr therapeutics n.v. - ordinary shares earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: proqr.com
PDF AX-0810 targeting NTCP for cholestatic diseases to be first ProQR Axiomerâ„¢ RNA editing program to enter the clinic Company to host virtual Investor and Analyst Event in [Read more]